Top compounds associated with response to HIRA

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	Sorafenib	CCLE	pan-cancer	AAC	0.028	0.6
mRNA	cimetidine	CTRPv2	pan-cancer	AAC	-0.042	0.6
mRNA	BRD-K71781559	CTRPv2	pan-cancer	AAC	0.024	0.6
mRNA	cediranib	CTRPv2	pan-cancer	AAC	0.034	0.6
mRNA	tretinoin:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.022	0.6
mRNA	BRD-K79669418	CTRPv2	pan-cancer	AAC	-0.032	0.6
mRNA	piperlongumine	GDSC1000	pan-cancer	AAC	-0.019	0.6
mRNA	lenalidomide	FIMM	pan-cancer	AAC	-0.095	0.6
mRNA	UNC0638:navitoclax (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.023	0.6
mRNA	CID-5951923	CTRPv2	pan-cancer	AAC	-0.023	0.6

Download CSV